Alpha Cognition (ACOG) Return on Sales (2025 - 2026)

Alpha Cognition (ACOG) posted quarterly Return on Sales of 0.03% for Q4 2025, down 711.56% quarter-over-quarter from 0.0% in Q3 2025.

Alpha Cognition (ACOG) Return on Sales (2025 - 2026) Analysis & Trends

Alpha Cognition's Return on Sales history runs 1 years deep, the most recent figure standing at 0.03% for Q4 2025.

In Q4 2025, Return on Sales changed N/A year-over-year to 0.03%; the TTM figure through Dec 2025 stood at 0.02% (changed N/A YoY), while the FY2025 annual figure was 0.04%, changed N/A from the prior year.
Return on Sales for Q4 2025 stood at 0.03%, down from 0.0% in the prior quarter.
The five-year high for Return on Sales was 0.0% in Q3 2025, with the low at 0.08% in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	0.00%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	0.00%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	0.00%
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-0.05%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	0.00%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	0.00%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	0.00%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	0.00%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	0.00%
10	Alpha Cognition	219.48 Mn	178.04 Mn	5.70 Mn	-0.01%

Download Data